Supplementary Material for: Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children Fisher D.M. Rosenfeld R.G. Jaron-Mendelson M. Amitzi L. Koren R. Hart G. 10.6084/m9.figshare.4840370.v1 https://karger.figshare.com/articles/figure/Supplementary_Material_for_Pharmacokinetic_and_Pharmacodynamic_Modeling_of_MOD-4023_a_Long-Acting_Human_Growth_Hormone_in_Growth_Hormone_Deficiency_Children/4840370 <i>Background/Aims:</i> MOD-4023 is a long-acting human growth hormone (hGH) in clinical trials for the treatment of growth hormone deficiency (GHD). A key goal is maintenance of serum concentrations of insulin-like growth factor (IGF) 1 within normal range throughout GH dosing. The study aimed to develop a pharmacokinetic model for MOD-4023 and a pharmacodynamic model for the effect of MOD-4023 on IGF-1 to allow estimation of peak and mean IGF-1 and to identify the optimal IGF-1 sampling day. <i>Methods:</i> MOD-4023 (0.25, 0.48, or 0.66 mg/kg) was administered weekly for 12 months to 41 GH-naive GHD children (age 3–11 years). The control group (<i>n</i> = 11, age 4–9 years) received daily recombinant human growth hormone (r-hGH; 34 µg/kg). Sparse samples (4/subject) were obtained to determine serum concentrations of MOD-4023 or r-hGH and IGF-1. <i>Results:</i> A 2-compartment pharmacokinetic model with first-order absorption fit MOD-4023 data well; a 1-compartment model was appropriate for r-hGH. For both, weight-normalized systemic parameters were preferred over allometric scaling. For MOD-4023, an indirect model fit IGF-1 SDS data well; baseline IGF-1 increased over time. At steady state, samples obtained 4 days following dose administration predicted mean IGF-1 SDS during the dosing interval well. <i>Conclusion:</i> The IGF-1 profile is consistent with the weekly dosing interval. Sampling 4 days following dose administration allows estimation of mean IGF-1 SDS during the dosing interval in GHD patients. 2017-04-11 11:58:51 Growth hormone Growth hormone deficiency Growth hormone replacement Growth in children Insulin growth factor 1 Long-acting growth hormone Weekly growth hormone Pharmacokinetic/pharmacodynamic modeling